The Inadequate Global Policy Response to Trade-Related Intellectual Property Rights: Impact on Access to Medicines in Low- and Middle-Income Countries
Lisa Forman
Maryland Journal of International Law, 2016
View PDFchevron_right
Global Issues and Business in International Relations: Intellectual Property Rights and Access to Medicines
Yoshiko KOJO
International Relations of the Asia-Pacific, 2018
View PDFchevron_right
Medicine procurement and the use of flexibilities in the Agreement on Trade-Related Aspects of Intellectual Property Rights, 2001-2016
Brigit Toebes
Bulletin of the World Health Organization, 2018
View PDFchevron_right
Policy & practice Medicine procurement and the use of flexibilities in the Agreement on Trade-Related Aspects of Intellectual Property Rights, 2001–2016
Brigit Toebes
View PDFchevron_right
Trade Rules and Intellectual Property Protection for Pharmaceuticals
Valbona Muzaka
View PDFchevron_right
Intellectual Property Rights In Bilateral Investment Treaties and Access to Medicines: the Case of Latin America
Rosa Castro
The Journal of World Intellectual Property, 2006
View PDFchevron_right
The WTO’s Compulsory Licencing of Patented Pharmaceuticals: Implementation Challenges
Milorad Stamenovic
Međunarodna politika 75(1190):39-55, 2024
View PDFchevron_right
Implications of TRIPS Flexibilities for Access to Noncommunicable Disease Medicines in Low and Middle Income Countries
Saba Danawala
View PDFchevron_right
TRIPS-Plus Free Trade Agreements and Access to Medicines
Susan Sell
Liverpool Law Review, 2007
View PDFchevron_right
Excessive prices and access to medicines – Compulsory licensing as an anticompetitive remedy under the TRIPS Agreement
Behrang Kianzad
2019
View PDFchevron_right
The Role of Intellectual Property Rights on Access to Medicines in the WHO African Region: 25 Years After the TRIPS Agreement
André LOUA
2020
View PDFchevron_right
The Doha Round's Public Health Legacy: Strategies for the Production and Diffusion of Patented Medicines under the Amended TRIPS Provisions†
Jerome Reichman
Journal of International Economic Law - J INT ECON LAW, 2007
View PDFchevron_right
A New Trade Framework for Global Healthcare R&D
James Love
PLoS Biology, 2004
View PDFchevron_right
PRODUCT PATENTS AND ACCESS TO INNOVATIVE MEDICINES IN A POST-TRIPS ERA
Jayashree WAtal
SSRN, 2019
View PDFchevron_right
Impacts of intellectual property provisions in trade treaties on access to medicine in low and middle income countries: a systematic review
Warren Kaplan
Globalization and Health
View PDFchevron_right
Developing Countries and Intellectual Property Enforcement Measures: Improving Access to Medicines through WTO Dispute Settlement
Melissa Blue Sky
View PDFchevron_right
Strong patent rights accelerate the diffusion of new medicines across countries
Mark Schankerman
2017
View PDFchevron_right
Promoting Access to Medical Technologies and Innovation - Intersections between Public Health, Intellectual Property and Trade
Roger Kampf
1900
View PDFchevron_right
Implications of bilateral free trade agreements on access to medicines
Carlos Correa
Bulletin of The World Health Organization, 2006
View PDFchevron_right
Rising Powers, Emerging Markets: Implications of Multipolarity for Intellectual Property Rules, Access to Medicines and Global Health
Suerie Moon
View PDFchevron_right
What is the impact of intellectual property rules on access to medicines? A systematic review
Brigitte Tenni
Globalization and Health
View PDFchevron_right
Effects of TRIPSPlus Provisions in International Trade Agreements upon Access to Medicines in Developing Countries
Sandeep Mittal
Journal of Intellectual Property Rights (JIPR) : [776] ISSN: 0975-1076 (Online); 0971-7544 (Print) JIPR Vol.22(6) [November 2017] Page(s): 295-302, 2017
View PDFchevron_right
Lisa Forman, "Human Rights Impact Assessment Of Trade-Related Intellectual Property Rights: A Key Strategy In Post-2015 Efforts To Improve Access To Safe And Accessible Medicines" (2013)
Lisa Forman
(2013) 1:1 Journal of Health Diplomacy
View PDFchevron_right
Effects Of The Trade Related Aspects of Intellectual Property (TRIPS) On Access to Pharmaceuticals in Developing Countries
Birute Aleknaite
View PDFchevron_right
CROSS-SECTIONAL ANALYSIS OF THE COUNTRIES AND CORRESPONDING TRIPS FLEXIBILITIES FOR PHARMACEUTICALS
Milorad Stamenovic
Auditor, 2023
View PDFchevron_right
Compulsory Licensing of Patented Pharmaceutical Inventions: Evaluating the Options
Jerome Reichman
Edward Elgar Publishing eBooks, 2013
View PDFchevron_right
Gold, R. and J-F Morin, 2012, “Promising Trends in Access to Medicines”, Global Policy, vol. 3(2), p. 231-237.
E. Richard Gold, Jean-Frederic Morin
View PDFchevron_right
Patents and the Trans-Pacific Partnership: How TPP-style intellectual property standards may exacerbate the access to medicines problem in the East African Community
Olugbenga Ajani Olatunji, Bukola Faturoti
The International Trade Journal
View PDFchevron_right
Comment: Compulsory Licensing of Patented Pharmaceutical Inventions: Evaluating the Options
Jerome Reichman
The Journal of Law, Medicine & Ethics, 2009
View PDFchevron_right
Patents for Drugs and the Right to Development in International Law
Olasupo Owoeye
Law and Development Review, 2015
View PDFchevron_right
Analyzing the impact of trade and investment agreements on pharmaceutical policy: provisions, pathways and potential impacts
Lisa Forman
Globalization and Health
View PDFchevron_right
Balancing intellectual monopoly privileges and the need for essential medicines
Thomas Faunce
Globalization and Health, 2007
View PDFchevron_right
Licensing Life-Saving Drugs for Developing Countries: Evidence from the Medicines Patent Pool
Mark Schankerman
2021
View PDFchevron_right
Doha Declaration and access to drugs and medicines
Anjali Mohandas
View PDFchevron_right